Assessing quality of life on the day of chemotherapy administration underestimates patients’ true symptom burden

BACKGROUND: In chemotherapy trials quality of life (QOL) is assessed mostly at the days of chemotherapy administration (i.e. event-driven) during treatment and follows fixed time intervals in the aftercare phase (i.e. time-driven). Specific QOL impairments and treatment side-effects are known to be...

Descripción completa

Detalles Bibliográficos
Autores principales: Giesinger, Johannes M, Wintner, Lisa M, Zabernigg, August, Gamper, Eva-Maria, Oberguggenberger, Anne S, Sztankay, Monika J, Kemmler, Georg, Holzner, Bernhard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4198707/
https://www.ncbi.nlm.nih.gov/pubmed/25305067
http://dx.doi.org/10.1186/1471-2407-14-758

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4198707/
https://www.ncbi.nlm.nih.gov/pubmed/25305067
http://dx.doi.org/10.1186/1471-2407-14-758

Ejemplares similares